Jie Wang‐Jairaj

Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial

Geoffrey Chupp, Eric Bradford, Frank C. Albers et al. · The Lancet Respiratory Medicine · 2017 · 571 citations

Asthma, Allergy, Health-related Quality +10

A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD

Surya P. Bhatt, Mark Dransfield, John Cockcroft et al. · International Journal of COPD · 2017 · 53 citations · Full text

Efficacy and safety of fluticasone furoate/vilanterol (50/25 mcg; 100/25 mcg; 200/25 mcg) in Asian patients with chronic obstructive pulmonary disease: a randomized placebo-controlled trial

Jinping Zheng, Teresita De Guia, Jie Wang‐Jairaj et al. · Current Medical Research and Opinion · 2015 · 51 citations · Full text

An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE)

Erin Gaughan, Tom Quinn, Andrew C. Mills et al. · American Journal of Respiratory and Critical Care Medicine · 2022 · 37 citations · Full text

Effect of raxibacumab on immunogenicity of Anthrax Vaccine Adsorbed: a phase 4, open-label, parallel-group, randomised non-inferiority study

Nancy Skoura, Jie Wang‐Jairaj, Oscar Della Pasqua et al. · The Lancet Infectious Diseases · 2020 · 22 citations

Vaccination, Cross-protection, Vaccine Development +8